Article
Presented by Martin G. Sanda, MD, University of Michigan, Ann Arbor.
Cretostimogene grenadenorepvec plus nivolumab shows promise in cisplatin-ineligible MIBC
Key updates from the AUA/ASRM male infertility guideline amendment
Yale Urology’s First Female Professor
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
ALLO-316 shows encouraging CAR activity in advanced ccRCC
Phase 1/2 trial of ONCT-534 in mCRPC has been terminated